Heparinase III limits rat arterial smooth muscle cell proliferation in vitro and in vivo

European Journal of Pharmacology

Volumn 351, Issue 1, 1998, Pages 79-83

  Silver, Paul J ^a   Moreau, Jean Pierre ^c   Denholm, Elizabeth ^b   Lin, YongQing ^b   Nguyen, Linh ^b   Bennett, Clark ^e   Recktenwald, Achim ^b   DeBlois, Denis ^d   Baker, Susan ^c   Ranger, Suzanne ^c  

^a IBEX Technologies Inc   (United States)

^b IBEX Technologies   (Canada)

^c MDS Inc   (Canada)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e NONE

Author keywords

Growth factor; Heparan sulfate proteoglycan; Restenosis; Smooth muscle, vascular

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; HEPARIN LYASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEOHEPARAN SULFATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY, EXTERNAL; CAROTID STENOSIS; CELL DIVISION; CELL MOVEMENT; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; POLYSACCHARIDE-LYASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032511219     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00293-3     Document Type: Article

References (15)

1. Benezra, M., Ben-Sasson, S.A., Regan, J., Chang, M., Bar-Shavit, R., Vlodavsky, I., 1994. Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds. Arterioscler. Thromb. 14, 1992-1999.
2. Castellot, J.J., Addonizio, M.L., Rosenberg, R.D., Karnovsky, M.J., 1981. Cultured endothelial cells produce a heparin-like inhibitor of cell growth. J. Cell Biol. 90, 372-379.
3. Castellot, J.J., Choay, J., Lormeau, J.-C., Petitou, M., Sache, E., Karnovsky, M.J., 1986. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells: II. Evidence for a pentasaccharide sequence that contains a 3-O-sulfate group. J. Cell Biol. 102, 1979-1984.
4. Clowes, A.W., Reidy, M.A., Clowes, M.M., 1983. Mechanisms of stenosis after arterial injury. Lab. Invest. 49, 208-215.
5. Ernst, S., Langer, R., Cooney, C.L., Sasisekharan, R., 1995. Enzymatic degradation of glycosaminoglycans. Crit. Rev. Biochem. Mol. Biol. 30, 387-444.
6. Fagin, J.A., Forrester, J.S., 1992. Growth factors, cytokines and vascular injury. Trends Cardiovasc. Med. 2, 90-94.
7. Ferns, G.A., Raines, E.W., Sprugel, K.H., Montani, A.S., Reidy, M.A., Ross, R.S., 1991. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253, 1129-1132.
8. Goren, H., Soker, S., Vlodavsky, I., Neufel, G., 1992. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267, 6093-6098.
9. Higashiyama, S., Abraham, J.A., Klagsbrun, M., 1993. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulfate. J. Cell Biol. 122, 933-940.
10. Khachigian, L.M., Owensby, D.A., Chesterman, C.N., 1992. A tyrosinated peptide representing the alternatively spliced exon of the platelet-derived growth factor A-chain binds specifically to cultured cells and interferes with binding of several growth factors. J. Biol. Chem. 267, 1660-1666.
11. Lindner, V., Reidy, M.A., 1991. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. USA 88, 3739-3743.
12. Ross, R., 1987. Platelet-derived growth factor. Annu. Rev. Med. 38, 71-79.
13. Schmidt, A., Yoshida, K., Buddecke, E., 1992. The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues. J. Biol. Chem. 267, 19242-19247.
14. Vlodavsky, I., Miao, H.Q., Atzmon, R., Levi, E., Zimmerman, J., Bar-Shavit, R., Peretz, T., Ben-Sasson, S.A., 1995. Control of cell proliferation by heparan sulfate and heparin-binding growth factors. Thromb. Haemost. 74, 534-540.
15. Yayon, A., Klagsbrun, M., Esko, J.D., Leder, P., Ornitz, D.M., 1991. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-848.